These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 7961215

  • 21. In vitro activity of DU-6859a, a new fluorocyclopropyl quinolone.
    Marshall SA, Jones RN.
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2747-53. PubMed ID: 8109948
    [Abstract] [Full Text] [Related]

  • 22. The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents.
    Child J, Andrews J, Boswell F, Brenwald N, Wise R.
    J Antimicrob Chemother; 1995 Jun; 35(6):869-76. PubMed ID: 7559198
    [Abstract] [Full Text] [Related]

  • 23. In-vitro activity of PD 117 596, a new quinolone, against bacterial isolates from cancer patients.
    Rolston KV, LeBlanc B, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1990 Jul; 26(1):39-44. PubMed ID: 2211445
    [Abstract] [Full Text] [Related]

  • 24. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
    Wallrauch C, Voss A, Milatovic D, Braveny I.
    Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
    [Abstract] [Full Text] [Related]

  • 25. Comparative activities of eight quinolones against members of the Bacteroides fragilis group.
    Borobio MV, Conejo M, Ramirez E, Suarez AI, Perea EJ.
    Antimicrob Agents Chemother; 1994 Jun; 38(6):1442-5. PubMed ID: 8092852
    [Abstract] [Full Text] [Related]

  • 26. In-vitro activity of PD 131628, a new quinolone antimicrobial agent.
    Cooper MA, Andrews JM, Wise R.
    J Antimicrob Chemother; 1992 May; 29(5):519-27. PubMed ID: 1320603
    [Abstract] [Full Text] [Related]

  • 27. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics.
    Chin NX, Neu HC.
    J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856
    [Abstract] [Full Text] [Related]

  • 28. Antimicrobial activity of CS-940, a new trifluorinated quinolone.
    Biedenbach DJ, Sutton LD, Jones RN.
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590
    [Abstract] [Full Text] [Related]

  • 29. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
    Jones RN, Ballow CH, Schentag JJ, Johnson DM, Deinhart JA.
    Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
    [Abstract] [Full Text] [Related]

  • 30. Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.
    Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1491-8. PubMed ID: 1324647
    [Abstract] [Full Text] [Related]

  • 31. In vitro activity of sparfloxacin compared with those of five other quinolones.
    Cantón E, Pemán J, Jimenez MT, Ramón MS, Gobernado M.
    Antimicrob Agents Chemother; 1992 Mar; 36(3):558-65. PubMed ID: 1320362
    [Abstract] [Full Text] [Related]

  • 32. Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    J Antimicrob Chemother; 1991 Jun; 27(6):793-9. PubMed ID: 1657857
    [Abstract] [Full Text] [Related]

  • 33. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria.
    Sedlock DM, Dobson RA, Deuel DM, Lesher GY, Rake JB.
    Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163
    [Abstract] [Full Text] [Related]

  • 34. In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
    Louie A, Baltch AL, Ritz WJ, Smith RP.
    Chemotherapy; 1991 Apr; 37(4):275-82. PubMed ID: 1665123
    [Abstract] [Full Text] [Related]

  • 35. In vitro evaluation of BAY Y3118, a new full-spectrum fluoroquinolone.
    Bremm KD, Petersen U, Metzger KG, Endermann R.
    Chemotherapy; 1992 Apr; 38(6):376-87. PubMed ID: 1288961
    [Abstract] [Full Text] [Related]

  • 36. In vitro activity of sparfloxacin (CI-978, AT-4140, and PD 131501). A quinolone with high activity against gram-positive bacteria.
    Cohen MA, Huband MD, Mailloux GB, Yoder SL, Roland GE, Heifetz CL.
    Diagn Microbiol Infect Dis; 1991 Apr; 14(5):403-15. PubMed ID: 1665775
    [Abstract] [Full Text] [Related]

  • 37. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone.
    Robbins MJ, Baskerville AJ, Sanghrajka M, Mumtaz G, Felmingham D, Ridgway GL, Grüneberg RN.
    Diagn Microbiol Infect Dis; 1989 Apr; 12(3 Suppl):65S-76S. PubMed ID: 2791500
    [Abstract] [Full Text] [Related]

  • 38. The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.
    Wise R, Andrews JM, Brenwald N.
    J Antimicrob Chemother; 1993 Apr; 31(4):497-504. PubMed ID: 8390433
    [Abstract] [Full Text] [Related]

  • 39. In vitro antibacterial activity of Q-35, a new fluoroquinolone.
    Ito T, Otsuki M, Nishino T.
    Antimicrob Agents Chemother; 1992 Aug; 36(8):1708-14. PubMed ID: 1329626
    [Abstract] [Full Text] [Related]

  • 40. Comparative in vitro activity of sparfloxacin (AT 4140, RP 64206--SPFX) against 275 multiresistant clinical isolates.
    Giamarellou H, Voutsinas D, Xirouchaki E.
    J Chemother; 1992 Feb; 4(1):12-5. PubMed ID: 1328554
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.